
cfdx develops precision neuroscience therapies and tools to improve diagnosis and treatment of brain disorders. The company combines AI-driven biology and computational neuroscience with experimental biology to identify targets and design interventions. It operates as a B2B biotech / AI biology company, working with pharmaceutical companies, research institutions, and clinical partners. Core technologies include machine learning, computational modeling, and experimental neurobiology. cfdx targets the neuroscience drug-discovery and clinical diagnostics market at the intersection of AI and biology.

cfdx develops precision neuroscience therapies and tools to improve diagnosis and treatment of brain disorders. The company combines AI-driven biology and computational neuroscience with experimental biology to identify targets and design interventions. It operates as a B2B biotech / AI biology company, working with pharmaceutical companies, research institutions, and clinical partners. Core technologies include machine learning, computational modeling, and experimental neurobiology. cfdx targets the neuroscience drug-discovery and clinical diagnostics market at the intersection of AI and biology.